Intuitive Surgical (NASDAQ:ISRG) EVP Sells $178,780.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Gary Loeb sold 400 shares of the firm’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $446.95, for a total value of $178,780.00. Following the completion of the transaction, the executive vice president owned 6,120 shares in the company, valued at $2,735,334. This represents a 6.13% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Stock Up 0.1%

ISRG stock opened at $432.27 on Thursday. Intuitive Surgical, Inc. has a twelve month low of $417.74 and a twelve month high of $603.88. The stock’s 50 day moving average is $466.62 and its 200-day moving average is $515.53. The firm has a market capitalization of $153.09 billion, a PE ratio of 52.40, a P/E/G ratio of 3.45 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. The company had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a return on equity of 15.98% and a net margin of 28.15%.Intuitive Surgical’s revenue was up 23.0% on a year-over-year basis. During the same period last year, the business posted $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently commented on ISRG shares. Citigroup raised Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price target for the company in a research report on Wednesday, March 11th. Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 30th. UBS Group decreased their price target on Intuitive Surgical from $570.00 to $550.00 and set a “neutral” rating for the company in a research report on Tuesday, March 17th. Mizuho set a $525.00 price target on Intuitive Surgical and gave the company a “neutral” rating in a research report on Monday, April 13th. Finally, Truist Financial decreased their price target on Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research report on Wednesday, April 15th. Eighteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $581.91.

Institutional Trading of Intuitive Surgical

A number of large investors have recently bought and sold shares of the company. Gibbs Wealth Management increased its position in Intuitive Surgical by 58.7% in the first quarter. Gibbs Wealth Management now owns 3,557 shares of the medical equipment provider’s stock worth $1,640,000 after buying an additional 1,316 shares during the last quarter. Alamar Capital Management LLC purchased a new stake in Intuitive Surgical in the first quarter worth $1,643,000. Davis R M Inc. increased its position in Intuitive Surgical by 1.7% in the first quarter. Davis R M Inc. now owns 56,581 shares of the medical equipment provider’s stock worth $26,083,000 after buying an additional 943 shares during the last quarter. Cetera Investment Advisers grew its position in shares of Intuitive Surgical by 2.8% in the first quarter. Cetera Investment Advisers now owns 120,628 shares of the medical equipment provider’s stock valued at $55,608,000 after purchasing an additional 3,236 shares in the last quarter. Finally, NewEdge Wealth LLC grew its position in shares of Intuitive Surgical by 21.6% in the first quarter. NewEdge Wealth LLC now owns 33,535 shares of the medical equipment provider’s stock valued at $15,459,000 after purchasing an additional 5,950 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.